PharmaBoardroom

Jon Helsdingen – General Manager, AbbVie Switzerland

AbbVie Switzerland's Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office move, the acquisition and integration of…

Top 10 Global Generics & Biosimilars Companies

The top ten global generics and biosimilars companies according to a recent Informa Pharma Intelligence ranking for 2019. Sandoz leads the way in…

Pharma Country Managers: The COVID Generation

While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive, working around the clock to ensure…

France: ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal;…

The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…

Population Health: Access & AntiVax Challenges

Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to clean water. It is estimated by global…

Viatris: Cost-Cutting Needed at New Generics Behemoth

In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and Pfizer's Upjohn generics unit finally…

Stefan Hendriks – Global Head Cell & Gene, Novartis…

Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression to becoming the global leader in…

Tim Philippi – Executive Director, Singaporean-German…

The SGC's Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance of healthcare and the life sciences…

Khalid Saleh – Managing Director, Mera Pharma

Mera Pharma’s Khalid Saleh introduces the Swiss-headquartered but MENA-focused company, how it plans to expand via CMOs, and its evolution from food…

JP Morgan 2021 Virtual Healthcare Conference: A Course Correction…

David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual format, noting potential changes in…

5 Top Trends in Chinese Healthcare & Biopharma in 2020

2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being discovered in China around the beginning…

Embryonic Gene Editing: How Far is Too Far to Find a Treatment…

Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing. With CRISPR technology again in the…

Tagged with